AAPS Gateway 2012: International Centre for Diffraction Data - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAPS Gateway 2012: International Centre for Diffraction Data


International Centre for Diffraction Data
12 Campus Boulevard
Newtown Square, PA 19073
USA
Phone: 610.325.9814
Fax: 610.325.9823
Email: marketing@icdd.com
Website: www.icdd.com

ICDD is a not-for-profit corporation dedicated to the collecting, editing and publishing of the Powder Diffraction File (PDF) databases. The PDF databases are designed for material identification and characterization.

Our mission is to be the world center for quality diffraction and related data to meet the needs of the technical community. We promote the application of materials characterization methods in science and technology by providing forums for the exchange of ideas and information. We sponsor the Pharmaceutical Powder X-ray Diffraction Symposium (PPXRD), Denver X-ray Conference; its proceedings, Advances in X-ray Analysis and the journal, Powder Diffraction.

Visit our Booth #2613
We invite you to visit our booth for a demonstration of our PDF-4/Organics 2013 database.

We also invite you to attend our free workshop on Monday, October 15th, from 12:00–3:00 p.m., in Room W 471 B at the McCormick Place titled, The Identification of API Polymorphs and Formulation Analysis Using X-ray Powder Diffraction and the PDF-4/Organics Database.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here